logo

AHR

American Healthcare·NYSE
--
--(--)
--
--(--)
5.69 / 10
Netural

Fundamental rating is neutral (5.7/10). Asset‑MV and PB‑ROE rank high, boosting outlook, while Revenue‑MV is positive. Profit‑MV, Net‑income‑Revenue and Cash‑UP are weak, dragging scores. Growth metrics show modest YoY revenue rise and strong equity growth.

Fundamental(5.69)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value-0.26
Score3/3
Weight23.95%
1M Return4.88%
Net assets per share (growth rate compared to beginning of year %)
Value24.37
Score2/3
Weight-0.48%
1M Return-0.13%
Total operating revenue (YoY growth rate %)
Value9.15
Score1/3
Weight1.44%
1M Return0.42%
Profit-MV
Value-0.79
Score0/3
Weight1.18%
1M Return0.26%
Net income-Revenue
Value-1.92
Score0/3
Weight2.84%
1M Return0.70%
PB-ROE
Value0.31
Score3/3
Weight47.58%
1M Return7.45%
Shareholders’ equity attributable to parent company (growth rate compared to beginning of year %)
Value46.85
Score2/3
Weight2.87%
1M Return0.74%
Income tax / Total profit (%)
Value-45.58
Score2/3
Weight4.28%
1M Return1.06%
Cash-UP
Value-0.85
Score1/3
Weight11.25%
1M Return2.62%
Asset-MV
Value0.04
Score2/3
Weight5.09%
1M Return1.04%
Is AHR fundamentally strong?
  • AHR scores 5.69/10 on fundamentals and holds a Fair valuation at present. Backed by its 2.46% ROE, 3.13% net margin, 127.03 P/E ratio, 2.64 P/B ratio, and 244.83% earnings growth, these metrics solidify its Netural investment rating.